Stock research
ROIV Roivant Sciences Ltd.
Healthcare • Biotechnology
Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases,...…
Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company dedicated to discovering and advancing innovative therapeutic drugs. The firm's development pipeline targets a broad spectrum of diseases, including various forms of solid tumors and oncologic malignancies, hematological disorders like sickle cell disease and warm autoimmune hemolytic anemia, as well as rare conditions such as hypophosphatasia. Additionally, Roivant is developing treatments for immunological and dermatological ailments, including psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, thyroid eye diseases, and sarcoidosis, alongside tackling infections like staph aureus bacteremia. Founded in 2014, its operations are based in London, United Kingdom.
1Y change
+199.82%
Range high
$36.81
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in ROIV?
Price
Showing 1Y history. Source: FMP historical price full.
- Prev Close
- $34.52
- Day High
- $34.50
- Day Low
- $33.54
- 52w High
- $37.00
- 52w Low
- $10.90
- Volume
- 5,174,199
- Avg Volume
- Beta
- 1.108
* TTM/most recent where available
Company
- Ticker
- ROIV
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- GB
- CEO
- Matthew Gline
- Employees
- 721
- Website
- roivant.com
Key Metrics
- Market Cap
- 24.5B
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).